The growing use of molecular imaging helps to control and monitor dosage for increased safety and effectiveness. Molecular imaging agents become the scientific tools for moving a concept from bench work to clinic product development. This special issue provides original research and review of new trends in molecular imaging agent development.
Among clinic molecular imaging modalities, radionuclide imaging technique is the most sensitive and could provide target-specific information. The radiotracer could noninvasively assess disease treatment endpoints which used to rely almost exclusively on biopsies and histopathological assays.
L. In summary, molecular imaging enables the comprehensive characterization of therapeutic intervention and can be used in preclinical studies, pharmacokinetic studies, dosefinding studies, and proof-of-concept studies. Molecular imaging technologies promote the discovery and development of personalized medicine.
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